Galvus Met is a combination medication used in the management of type 2 diabetes. It contains two active ingredients: Vildagliptin and Metformin Hydrochloride.

Key features and uses of Galvus Met include:

• Diabetes Management: Galvus Met is prescribed to individuals with type 2 diabetes to help control and regulate blood sugar levels.
• Dual Mechanism: It combines the effects of Vildagliptin (a Dipeptidyl Peptidase-4 (DPP-4) inhibitor) and Metformin (an anti-diabetic medication) to address blood sugar regulation from multiple angles.

The combination of Vildagliptin and Metformin is aimed at enhancing blood sugar control in individuals with type 2 diabetes.

Directions for Use:

• Take Galvus Met as prescribed by your healthcare provider, typically as an oral tablet.
• Follow the recommended dosage instructions provided by your healthcare professional.

Caution:

• Use Galvus Met only as prescribed by a healthcare provider.
• Be aware of potential side effects and consult with a healthcare professional if you experience any adverse reactions.

Galvus Met is a combination medication that plays a vital role in helping individuals with type 2 diabetes manage their condition. It should be used in accordance with the specific guidance provided by a healthcare provider, and potential side effects should be monitored and reported. If you have questions or concerns about the use of Galvus Met, consult your healthcare provider.